The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts

Olga Aprelikova(University of North Carolina at Chapel Hill), John E. Niederhuber(Johns Hopkins University), Richard J. Simpson(University of Arizona), Yu Xiang(Inner Mongolia University), Simone John(National Institutes of Health), John Palla(National Institutes of Health), Ming Yi(Science Applications International Corporation (United States)), Robert M. Stephens(National Cancer Institute), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Bih-Rong Wei(Center for Cancer Research), John I. Risinger(National Cancer Institute)
Cell Cycle
November 1, 2010
10.4161/cc.9.21.13674
Cited by 152

Related Papers

Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database
|PROTEOMICS|2005|792
The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
|Proceedings of the National Academy of Sciences|1999|632
Proteomics Analysis of A33 Immunoaffinity-purified Exosomes Released from the Human Colon Tumor Cell Line LIM1215 Reveals a Tissue-specific Protein Signature
|Molecular & Cellular Proteomics|2009|583
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508